NR1H4 and metabolic dysfunction-associated steatotic liver disease: HDCA, a type of secondary BA generated by the gut microbiota in the small intestine, has shown an inverse relationship with the occurrence and severity of non-alcoholic fatty liver disease (NAFLD) across various mouse models, and its alleviating effect on NAFLD has been attributed to the inhibition of intestinal FXR (41, 42).